Allarity Therapeutics (ALLR) Misses Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts ALLR Hot Sheet
Join SI Premium – FREE
Allarity Therapeutics (NASDAQ: ALLR) reported Q2 EPS of ($0.15).
For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
- NY Fed survey shows rising unemployment fears, mixed financial outlook
- Pharvaris B.V. (PHVS) PT Raised to $65 at Cantor Fitzgerald
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
